Atossa Therapeutics
ATOS
#10635
Rank
A$37.22 M
Marketcap
A$3.73
Share price
1.52%
Change (1 day)
218.85%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -A$56.14 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$48.4 Million a decrease over its 2024 earnings that were of -A$35.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$56.14 Million15.99%
2025 -A$48.4 Million36.33%
2024 -A$35.51 Million-15.25%
2023 -A$41.9 Million11.62%
2022 -A$37.53 Million30.84%
2021 -A$28.69 Million15.58%
2020 -A$24.82 Million3.41%
2019 -A$24 Million51.16%
2018 -A$15.88 Million40.41%
2017 -A$11.31 Million27.54%
2016 -A$8.87 Million-47.49%
2015 -A$16.89 Million-17.25%
2014 -A$20.41 Million35.91%
2013 -A$15.02 Million112.3%
2012 -A$7.08 Million46.53%
2011 -A$4.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.16 B-69,117.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$1.91 B-3,755.59%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$1.91 B-3,753.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
A$58.01 M-210.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-A$0.14 Billion 164.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-A$10.92 Million-79.17%๐Ÿ‡บ๐Ÿ‡ธ USA